Cambridge Healthtech Institute’s 7th Annual
Gene Therapy Manufacturing and CMC
Improving the Production, Control, and Commercialisation of Genetic Medicines
11-12 March 2026
Join us at the 8th Annual Gene Therapy Manufacturing and CMC track to discover the latest strategies to improve the production, control, and commercialisation of viral and non-viral gene therapies against an increasingly challenging regulatory environment. The event explores the latest developments in novel capsids and engineered vectors, upstream and downstream processing, working with CDMOs, cell line development, process intensification, AI and digitalisation, gene editing, and mRNA-LNP, showcasing how next-generation platforms are enabling safer, more efficient, and cost-effective gene therapies at scale.
Coverage will include, but is not limited to:
- Scaling & Commercialising Gene Therapies – commercialisation strategies, FDA platform guidance, working with CDMOs, scalability, and reducing COGs
- Capsid Engineering & Novel Vectors – designing safer, more effective capsids, dual-vector systems, and manufacturability challenges
- AI & Automation in Gene Therapy Manufacturing – leveraging digital tools for process optimisation and efficiency
- Plasmid & Promoter Optimisation – enhancing yields, transgene expression, and quality in vector production
- Upstream Innovations – scaling stable systems, process intensification, and raw material management
- Cell Line Development for Viral Vectors – transitioning to stable producer cell lines for higher productivity and reduced costs
- Downstream Processing Bottlenecks – overcoming chromatography challenges, empty capsid removal, and balancing purity and yield
- Advanced Analytics in DSP – tools for full/empty capsid separation and innovative impurity removal strategies
- Gene Editing & LNP Manufacturing – CMC considerations, LNP formulation design, and process intensification for mRNA-LNPs
- Regulatory & Industry Perspectives – insights on scaling novel delivery systems and ensuring compliance
The deadline for priority consideration is Friday 19 September
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: